Abbott Laboratories (NYSE:ABT) Stake Decreased by McCollum Christoferson Group LLC

McCollum Christoferson Group LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 75,318 shares of the healthcare product maker’s stock after selling 1,359 shares during the period. Abbott Laboratories […]

Related Keywords

Raymond James ,Andreaf Wainer ,Cornerstone Planning Group ,Citigroup ,Investment Management ,Halpern Financial Inc ,Morgan Stanley ,Wells Fargo Company ,Altshuler Shaham Ltd ,Securities Exchange Commission ,Financial Services ,Mccollum Christoferson Group ,Abbott Laboratories ,Free Report ,Collum Christoferson Group ,Shaham Ltd ,Planning Group ,Exchange Commission ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,Nyse Abt ,Abt ,Medical ,00282410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,